Factors determining the use of hormone replacement therapy in recent naturally postmenopausal women participating in the French SU.VI.MAX cohort

S. Mohammed-Cherif; S. Briançon; G. Potier de Courcy; Paul Preziosi; Bernadette Fieux; Marjorie Zarebska; Pilar Galán; Serge Hercberg

doi:10.1023/a:1007616029063

Back

Factors determining the use of hormone replacement therapy in recent naturally postmenopausal women participating in the French SU.VI.MAX cohort

Article 2000 en

Related publications

Article2007

Coagulation Factors, Postmenopausal Hormone Replacement Therapy and the Risk of Venous Thrombosis: The WHI Clinical Trials of Postmenopausal Hormone Therapy.

Mary Cushman, Joseph C. Larson, Frits R. Rosendaal, Lawrence S. Phillips, Barbara V. Howard, J. David Curb, Jennifer Hays, Alison E. Baird, Charles B. Eaton, Susan R. Heckbert, Randall S. Stafford

Blood

Article2006

Tanning Devices: Behaviour of French Adults Participating to the SU.VI.MAX Cohort

Khaled Ezzedine, Emmanuelle Mauger, Pilar Galán, Serge Hercberg, Denis Malvy, Christiane Guinot

Article2000

Determinants of thyroid volume in healthy French adults participating in the SU.VI.MAX cohort

Xavier Barrère, Pierre Valeix, Paul Preziosi, Michel Bensimon, Bruno Pelletier, Pilar Galán, Serge Hercberg

Article2002

[Adverse cardiovascular effects of postmenopausal hormone replacement therapy].

Saskia Middeldorp, H.R. Büller, Jan P. Vandenbroucke, FM Helmerhorst, Frits R. Rosendaal

PubMed

Letter2002

Hormone Replacement Therapy, Prothrombotic Mutations, and the Risk of Incident Nonfatal Ischemic Stroke in Postmenopausal Women

Rozenn N. Lemaître, Bruce M. Psaty, Susan R. Heckbert, Nicholas L. Smith, W. T. Longstreth, Frits R. Rosendaal

Arteriosclerosis Thrombosis and Vascular Biology

Factors determining the use of hormone replacement therapy in recent naturally postmenopausal women participating in the French SU.VI.MAX cohort

Discussion(0)

Related publications

Coagulation Factors, Postmenopausal Hormone Replacement Therapy and the Risk of Venous Thrombosis: The WHI Clinical Trials of Postmenopausal Hormone Therapy.

Tanning Devices: Behaviour of French Adults Participating to the SU.VI.MAX Cohort

Determinants of thyroid volume in healthy French adults participating in the SU.VI.MAX cohort

[Adverse cardiovascular effects of postmenopausal hormone replacement therapy].

Hormone Replacement Therapy, Prothrombotic Mutations, and the Risk of Incident Nonfatal Ischemic Stroke in Postmenopausal Women